Effect of Femo-Klim on quality of life in young women with hormonal changes

DOI: https://doi.org/10.29296/25877305-2022-03-02
Issue: 
3
Year: 
2022

M. Khabibulina, Candidate of Medical Sciences; M. Shamilov Ural State Medical University,
Yekaterinburg

The effect of the natural non-hormonal remedy Femo-Klim on quality of life (QoL) was studied in 136 women in the late fertile period with hypoestrogenemism. The study used the Feeling-Activity-Mood questionnaire and the Short Form 36 Health Quality Survey. Femo-Klim was found to be an effective drug in the therapy of menopausal manifestations in women with altered hormonal levels and has a positive effect on their QoL.

Keywords: 
therapy
quality of life
late fetal period
hypoestrogenism
Femo-Klim



References: 
  1. Blumel J.E., Castello C. et al. Quality of life after the menopause – a population study. Maturitas. 2009; 34 (1): 17–23. DOI: 10.1016/s0378-5122(99)00081-x
  2. Habibulina M.M. Vlijanie gipoestrogenemii na kachestvo zhizni zhenschin s arterial'noj gipertoniej v period premenopauzy. Kardiologija. 2013; 53 (11): 45–8.
  3. Habibulina M.M., Dmitriev A.N., Fedorova N.N. Kachestvo zhizni molodyh zhenschin s arterial'noj gipertenziej s gipoestrogenemiej s «metabolicheski zdorovym» vistseral'nym ozhireniem. Evrazijskij Sojuz Uchenyh. 2017; 1 (34): 25–9.
  4. Habibulina M.M. Shamilov M.D. Kachestvo zhizni molodyh zhenschin s arterial'noj gipertenziej i izmenennym gormonal'nym fonom. Vrach. 2021; 32 (1): 46–9. DOI: 10.29296/25877305-2021-01-09
  5. Chazova I.E., Smetnik V.P., Balan V.E. Vedenie zhenschin s serdechno-sosudistym riskom v peri- i postmenopauze:konsensus rossijskih kardiologov i ginekologov. Consilium medicum. 2008; 10 (6): 5–18.
  6. Skornjakova M.N., Syrochkina M.A. Gipomenstrual'nyj sindrom. Rukovodstvo dlja vrachej. Ekaterinburg, 2008; 236 s.
  7. Smetnik V.P., Il'ina L.M. Korrektsija klimaktericheskogo sindroma (individualizatsija terapii). V kn. «Meditsina klimakterija». Litera, 2006; s. 217–74.
  8. Habibulina M.M. Kardiovaskuljarnyj risk pri estrogenodefitsite v doklimaktericheskih periodah. Ekaterinburg, 2014.
  9. Palacios S., Berrego R. The importance of preventive health care in postmenopausal women. Maturitas. 2005; 52 (Supl. 1): 53–60. DOI: 10.1016/j.maturitas.2005.06.013
  10. Rapeport N. Cardiovascular disease and hormone replacement therapy in post-menopausal women. Cardiovascular J S Afr. 2005; 16 (2): 76–80.
  11. Stein K.D., Jacobsen P.B. Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. J Pain Symptom. 2009; 19: 436–45.
  12. Menopauzal'naja gormonal'naja terapija i sohranenie zdorov'ja zhenschin zrelogo vozrasta: Klinicheskie rekomendatsii (protokol lechenija). M.: FGBU NTsGAiP, 2015.
  13. Hsia J., Langer R.D., Manson J.E. et al.; Women’s Health Initiative Investigators. Conjugated equine estrogens and coronary heart disease: the Women’s Health Initiative. Arch Intern Med. 2006; 166 (3): 357–65. DOI: 10.1001/archinte.166.3.357
  14. Pines A., Sturdee D.W., Birkhauser M.H. IMS Updated Recommendations on postmenopausal hormone therapy. Climacteric. 2007; 10 (3): 195–6. DOI: 10.1080/13697130701361657
  15. Habibulina M.M. Strukturno-geometricheskie izmenenija levogo zheludochka, endotelij-zavisimaja vazodilatatsija perifericheskih arterij, antigipertenzivnyj effekt ingibitorov angiotenzin-prevraschajuschego fermenta i zamestitel'naja gormonal'naja terapija u zhenschin s arterial'noj gipertenziej v premenopauze. Kardiovaskuljarnaja terapija i profilaktika. 2011; 10 (2): 24–8. DOI: 10.15829/1728-8800-2011-2-24-28
  16. Habibulina M.M., Dmitriev A.N. Sposob optimizatsii lechenija zhenschin kardiotropnoj terapiej i zamestitel'noj gormonal'noj terapiej pri estrogenodefitsite s arterial'noj gipertenziej v pozdnem reproduktivnom periode. Patent na izobretenie RU 2648470 C2, 26.03.2018 Zajavka №2016107890 ot 03.03.2016.
  17. Habibulina M.M. Terapija u zhenschin s arterial'noj gipertenziej i estrogenodefitsitom v pozdnem fertil'nom periode. Vrach. 2016; 4: 45–9.
  18. Habibulina M.M. Premenopauza: vlijanie terapii dirotonom i ZGT na kachestvo zhizni pri arterial'noj gipertenzii. Vrach. 2012; 7: 69–71.
  19. Habibulina M.M., Smolentseva A.A. Terapija trevozhnyh rasstrojstv u zhenschin s arterial'noj gipertenziej v period premenopauzy na ambulatornom etape. V sb.: V s'ezd kardiologov Ural'skogo federal'nogo okruga. Mat-ly s'ezda. 2011; s. 282–4.
  20. Doskin V.A., Lavrent'eva N.A., Miroshnikov M.P. Test differentsial'noj samootsenki funktsional'nogo sostojanija. Voprosy psihologii. 1999; 6: 48–54.
  21. Novik A.A., Ionova T.I. Rukovodstvo po issledovaniju kachestva zhizni v meditsine. SPb: Izdatel'skij dom «Neva», M.: «OLMA-PRESS Zvezdnyj mir», 2002; 320 s.
  22. Ware J.E. Measuring patients’ views: the optimum outcome measure. SF 36: a valid, reliable assessment of health from the patient’s point of view. BMJ. 1993; 306 (6890): 1429–30. DOI: 10.1136/bmj.306.6890.1429
  23. Ware J.E., Gandek B. Overview of the SF-36 Health Surveg and the International anality of Life Assessment (JQOLA). Projekt J Clin Epidemiol. 1998; 51 (11): 903–12. DOI: 10.1016/s0895-4356(98)00081-x
  24. The WHOQOL Group. What Quality of Life? The WHOQOL Group. World Health Forum. 1996; 17 (4): 354–6.
  25. Ovsjannikova T.V., Makarov I.O., Kulikov I.A. Klinicheskaja effektivnost' negormonal'nyh metodov terapii u zhenschin v perimenopauze. Akusherstvo, ginekologija, reproduktsija. 2013; 7 (3): 26–9.
  26. Petrova E., Kalistratov V., Polubojarinov P. i dr. Primenjaemyj pri klimakse preparat Femo-Klim – luchshee negormonal'noe reshenie gormonal'nyh problem. Vrach. 2019; 30 (1): 46–9. DOI: 10.29296/25877305-2019-01-08
  27. Habibulina M.M., Shamilov M.D. Vlijanie glitsina i lizinoprila na kachestvo zhizni zhenschin s arterial'noj gipertenziej i estrogenodefitsitom. Vrach. 2021; 32 (4): 38–42. DOI: 10.29296/25877305-2021-04-06
  28. Potupchik T., Veselova O., Evert L. i dr. Spektr farmakologicheskih effektov glitsina. Vrach. 2015; 12: 14–7.
  29. Radzinskij V.E., Dobretsova T.A. Menopauza kak mehanizm zhenskogo starenija. Fitoestrogeny – razvedka boem. StatusPraesens. Ginekologija. Akusherstvo. Besplodnyj brak. 2015; 2 (25): 51–8.
  30. Radzinskij V.E., Dobretsova T.A., Ryzhova T.E. Biologicheskaja rol' menopauzal'nogo perehoda i terapevticheskie vozmozhnosti fitoestrogenov. StatusPraesens. Ginekologija. Akusherstvo. Besplodnyj brak. 2015; 4 (27): 77–82.
  31. Tatarova N.A., Linde V.A., Zhidkova E.V. i dr. Negormonal'naja korrektsija klimaktericheskih rasstrojstv v peri- i postmenopauze. Effektivnaja farmakoterapija v akusherstve i ginekologii. 2009; 17: 12–5.
  32. Blumel J.E., Castello C. et al. Quality of life after the menopause – a population study. Maturitas. 2009; 34 (1): 17–23. DOI: 10.1016/s0378-5122(99)00081-x
  33. Khabibulina M.M. Effect of hypoestrogenemia on quality of life of premenopausal women with arterial hypertension. Kardiologiya. 2013; 53 (11): 45–8 (in Russ.).
  34. Khabibulina M.M., Dmitriev A.N., Fedorova N.N. Kachestvo zhizni molodykh zhenshchin s arterial’noi gipertenziei s gipoestrogenemiei s «metabolicheski zdorovym» vistseral’nym ozhireniem. Evraziiskii Soyuz Uchenykh. 2017; 1 (34): 25–9 (in Russ.).
  35. Khabibulina M., Shamilov M. Quality of life in young women with hypertension and an altered hormonal background. Vrach. 2021; 32 (1): 46–9 (in Russ.). DOI: 10.29296/25877305-2021-01-09
  36. Chazova I.E., Smetnik V.P., Balan V.E. Vedenie zhenshchin s serdechno-sosudistym riskom v peri- i postmenopauze:konsensus rossiiskikh kardiologov i ginekologov. Consilium medicum. 2008; 10 (6): 5–18 (in Russ.).
  37. Skornyakova M.N., Syrochkina M.A. Gipomenstrual’nyi sindrom. Rukovodstvo dlya vrachei. Ekaterinburg, 2008; 236 s. (in Russ.).
  38. Smetnik V.P., Il’ina L.M. Korrektsiya klimaktericheskogo sindroma (individualizatsiya terapii). V kn. «Meditsina klimakteriya». Litera, 2006; s. 217–74 (in Russ.).
  39. Khabibulina M.M. Kardiovaskulyarnyi risk pri estrogenodefitsite v doklimaktericheskikh periodakh.Yekaterinburg, 2014 (in Russ.).
  40. Palacios S., Berrego R. The importance of preventive health care in postmenopausal women. Maturitas. 2005; 52 (Supl. 1): 53–60. DOI: 10.1016/j.maturitas.2005.06.013
  41. Rapeport N. Cardiovascular disease and hormone replacement therapy in post-menopausal women. Cardiovascular J S Afr. 2005; 16 (2): 76–80.
  42. Stein K.D., Jacobsen P.B. Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. J Pain Symptom. 2009; 19: 436–45.
  43. Menopauzal’naya gormonal’naya terapiya i sokhranenie zdorov’ya zhenshchin zrelogo vozrasta: Klinicheskie rekomendatsii (protokol lecheniya). M.: FGBU NTsGAiP, 2015 (in Russ).
  44. Hsia J., Langer R.D., Manson J.E. et al.; Women’s Health Initiative Investigators. Conjugated equine estrogens and coronary heart disease: the Women’s Health Initiative. Arch Intern Med. 2006; 166 (3): 357–65. DOI: 10.1001/archinte.166.3.357
  45. Pines A., Sturdee D.W., Birkhauser M.H. IMS Updated Recommendations on postmenopausal hormone therapy. Climacteric. 2007; 10 (3): 195–6. DOI: 10.1080/13697130701361657
  46. Khabibulina M.M. Left ventricular structure and geometry, peripheral artery endotheliumdependent vasodilatation, antihypertensive effect of ACE inhibitors, and hormone replacement therapy in premenopausal women with arterial hypertension. Cardiovascular Therapy and Prevention. 2011; 10 (2): 24–8 (in Russ.). DOI: 10.15829/1728-8800-2011-2-24-28
  47. Khabibulina M.M., Dmitriev A.N. Sposob optimizatsii lecheniya zhenshchin kardiotropnoi terapiei i zamestitel’noi gormonal’noi terapiei pri estrogenodefitsite s arterial’noi gipertenziei v pozdnem reproduktivnom periode. Patent na izobretenie RU 2648470 C2, 26.03.2018 Zayavka №2016107890 ot 03.03.2016 (in Russ.).
  48. Khabibulina M. Therapy in women with hypertension and estrogen deficiency in the late fertile period. Vrach. 2016; 4: 45–9 (in Russ.).
  49. Khabibuliria M. Premenopause: impact of diroton therapy and hormone replacement therapy on quality of life in arterial hypertension. Vrach. 2012; 7: 69–71 (in Russ.).
  50. Khabibulina M.M., Smolentseva A.A. Terapiya trevozhnykh rasstroistv u zhenshchin s arterial’noi gipertenziei v period premenopauzy na ambulatornom etape. V sb.: V s»ezd kardiologov Ural’skogo federal’nogo okruga. Mat-ly s»ezda. 2011; s. 282–4 (in Russ.).
  51. Doskin V.A., Lavrent’eva N.A., Miroshnikov M.P. Test differentsial’noi samootsenki funktsional’nogo sostoyaniya. Voprosy psikhologii. 1999; 6: 48–54 (in Russ.)
  52. Novik A.A., Ionova T.I. Rukovodstvo po issledovaniyu kachestva zhizni v meditsine. SPb: Izdatel’skii dom «Neva», M.: «OLMA-PRESS Zvezdnyi mir», 2002; 320 s. (in Russ.).
  53. Ware J.E. Measuring patients’ views: the optimum outcome measure. SF 36: a valid, reliable assessment of health from the patient’s point of view. BMJ. 1993; 306 (6890): 1429–30. DOI: 10.1136/bmj.306.6890.1429
  54. Ware J.E., Gandek B. Overview of the SF-36 Health Surveg and the International anality of Life Assessment (JQOLA). Projekt J Clin Epidemiol. 1998; 51 (11): 903–12. DOI: 10.1016/s0895-4356(98)00081-x
  55. The WHOQOL Group. What Quality of Life? The WHOQOL Group. World Health Forum. 1996; 17 (4): 354–6.
  56. Ovsyannikova T.V., Makarov I.O., Kulikov I.A. Clinical efficacy of non-hormonal methods of therapy in perimenopausal women. Obstetrics, Gynecology and Reproduction. 2013; 7 (3): 26–9 (in Russ).
  57. Petrova E., Kalistratov V., Polyboyarinov P. et al. The menopause drug Femo-Klim is the best nonhormonal solution of hormonal problems. Vrach. 2019; 30 (1): 46–9 (in Russ). DOI: 10.29296/25877305-2019-01-08
  58. Khabibulina M., Shamilov M. The effect of glycine and lisinopril on quality of life in women with hypertension and estrogen deficiency Vrach. 2021; 32 (4): 38–42 (in Russ.). DOI: 10.29296/25877305-2021-04-06
  59. Potupchik T., Veselova O., Evert L. et al. A spectrum of pharmacological effects of glycine. Vrach. 2015; 12: 14–7 (in Russ).
  60. Radzinskii V.E., Dobretsova T.A. Menopauza kak mekhanizm zhenskogo stareniya. Fitoestrogeny – razvedka boem. StatusPraesens. Ginekologiya. Akusherstvo. Besplodnyi brak. 2015; 2 (25): 51–8 (in Russ).
  61. Radzinskii V.E., Dobretsova T.A., Ryzhova T.E. Biologicheskaya rol’ menopauzal’nogo perekhoda i terapevticheskie vozmozhnosti fitoestrogenov. StatusPraesens. Ginekologiya. Akusherstvo. Besplodnyi brak. 2015; 4 (27): 77–82 (in Russ).
  62. Tatarova N.A., Linde V.A., Zhidkova E.V. et al. Negormonal’naya korrektsiya klimaktericheskikh rasstroistv v peri- i postmenopauze. Effektivnaya farmakoterapiya v akusherstve i ginekologii. 2009; 17: 12–5 (in Russ.).